CAO/ARO/AIO-04 study final results of the multicentre, open-label, randomised, phase 3 trial. Zipfel., Schenk., Grenz., Lauchart., Viebahn. Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells. Comparative investigation of alloplastic materials for hernia repair with improved methodology.
Donor-HLA A24 is beneficial in clinical liver transplantation. Metastatic glucagonoma: Treatment with liver transplantation. Schenk., Zipfel., Kinder., Lauchart., Becker. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. Ueberberg., Tannapfel., Schenker., Viebahn., Uhl., Schneider., Meier.J. Pons JA, Yélamos J, Ramrez P,. Transplant International 27 (S3), 18 (2014). Long-term outcome of immunosuppression withdrawal after liver transplantation. Primary Hepatocyte Culture - A Model for the Study of Liver Preservation.